The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent

Biomaterials

Volumn 31, Issue 7, 2010, Pages 1723-1731

  Díaz López, Raquel ^a,b   Tsapis, Nicolas ^a,b   Santin, Mathieu ^c   Bridal, Sharon Lori ^c   Nicolas, Valérie ^a   Jaillard, Danielle ^a   Libong, Danielle ^d   Chaminade, Pierre ^d   Marsaud, Véronique ^a,b   Vauthier, Christine ^a,b   Fattal, Elias ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b IPSIT   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d University Paris Saclay   (France)

Author keywords

PEGylated phospholipids; Polymeric nanocapsules; Tumor distribution; Ultrasound contrast agent

Indexed keywords

CORE/SHELL STRUCTURE; ECHOGENIC; ELECTRONIC MICROSCOPY; EVAPORATION PROCESS; HISTOLOGICAL ANALYSIS; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; IN-VIVO; INTRAVENOUS INJECTIONS; LIQUID CORES; MONONUCLEAR PHAGOCYTE SYSTEMS; ORGANIC PHASE; PEG CONCENTRATION; PEGYLATED PHOSPHOLIPIDS; PERFLUOROOCTYL BROMIDE; POLY-LACTIDE-CO-GLYCOLIDE; POLYMERIC NANOCAPSULES; TISSUE DISTRIBUTIONS; TUMOR TARGETING; TUMOR TISSUES; ULTRASOUND CONTRAST AGENT; ULTRASOUND IMAGING; ZETA POTENTIAL MEASUREMENTS;

ACOUSTIC WAVES; CHROMATOGRAPHIC ANALYSIS; EMULSIFICATION; ENCAPSULATION; ETHYLENE; ETHYLENE GLYCOL; HYDROPHOBIC CHROMATOGRAPHY; HYDROPHOBICITY; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; SURFACE MORPHOLOGY; TUMORS; ULTRASONIC TRANSMISSION; ULTRASONICS; ZETA POTENTIAL;

NANOCAPSULES;

DISTEAROYLPHOSPHATIDYLETHANOLAMINE; ECHO CONTRAST MEDIUM; GLYCEROPHOSPHOLIPID; MACROGOL 2000; NANOCAPSULE; PERFLUOROOCTYL BROMIDE; PHOSPHOLIPID; POLYGLACTIN; POLYMER; SOLVENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; CHROMATOGRAPHY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; EMULSION; EVAPORATION; HISTOLOGY; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMAGING; IN VIVO STUDY; MICROSCOPY; MONONUCLEAR PHAGOCYTE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE; SURFACE PROPERTY; TISSUE DISTRIBUTION; TUMOR XENOGRAFT; ULTRASOUND; ZETA POTENTIAL;

ANIMALS; CHROMATOGRAPHY; COMPLEMENT ACTIVATION; COMPLEMENT C3; CONTRAST MEDIA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLUOROCARBONS; HUMANS; HYDROPHOBICITY; MICE; NANOCAPSULES; PANCREATIC NEOPLASMS; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; SURFACE PROPERTIES; ULTRASONICS;

AGOUTI PACA; MUS;

EID: 73549094450     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.11.044     Document Type: Article

References (40)

1. Hernot S., and Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 60 10 (2008) 1153-1166
2. Straub J.A., Chickering D.E., Church C.C., Shah B., Hanlon T., and Bernstein H. Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J Control Release 108 1 (2005) 21-32
3. Lindner J.R. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 3 6 (2004) 527-533
4. Klibanov A.L. Ultrasound molecular imaging with targeted microbubble contrast agents. J Nucl Cardiol 14 6 (2007) 876-884
5. Pisani E., Tsapis N., Paris J., Nicolas V., Cattel L., and Fattal E. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization. Langmuir 22 9 (2006) 4397-4402
6. Pisani E., Fattal E., Paris J., Ringard C., Rosilio V., and Tsapis N. Surfactant dependent morphology of polymeric capsules of perfluorooctyl bromide: influence of polymer adsorption at the dichloromethane-water interface. J Colloid Interface Sci 326 1 (2008) 66-71
7. Pisani E., Tsapis N., Galaz B., Santin M., Berti R., Taulier N., et al. Perfluorooctyl bromide polymeric capsules as dual contrast agents for ultrasonography and magnetic resonance imaging. Adv Funct Mater 18 19 (2008) 2963-2971
8. Ngo FC, Hall CS, Marsh JN, Fuhrhop RW, Allen JS, Brown P, et al. Evaluation of liquid perfluorocarbon nanoparticles as a blood pool contrast agent utilizing power Doppler harmonic imaging. 2000 IEEE Ultrasonics Symposium Proceedings 2000;1-2: 1931-1934.
9. Wickline S.A., Hughes M., Ngo F.C., Hall C.S., Marsh J.N., Brown P.A., et al. Blood contrast enhancement with a novel, non-gaseous nanoparticle contrast agent. Acad Radiol 9 (2002) S290-S293
10. Shive M.S., and Anderson J.M. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28 1 (1997) 5-24
11. Correas J.M., Bridal L., Lesavre A., Mejean A., Claudon M., and Helenon O. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 11 8 (2001) 1316-1328
12. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzym Regul 41 (2001) 189-207
13. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55 17 (1995) 3752-3756
14. Mosqueira V.C., Legrand P., Gulik A., Bourdon O., Gref R., Labarre D., et al. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials 22 22 (2001) 2967-2979
15. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 5153 (1994) 1600-1603
16. Owens III D.E., and Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307 1 (2006) 93-102
17. Bazile D., Prud'homme C., Bassoullet M.T., Marlard M., Spenlehauer G., and Veillard M. Stealth Me PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci 84 4 (1995) 493-498
18. Nobs L., Buchegger F., Gurny R., and Allemann E. Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods. Int J Pharm 250 2 (2003) 327-337
19. Veronese F.M., and Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today 10 21 (2005) 1451-1458
20. Fahmy T.M., Samstein R.M., Harness C.C., and Mark Saltzman W. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials 26 28 (2005) 5727-5736
21. Diaz-Lopez R., Tsapis N., Libong D., Chaminade P., Connan C., Chehimi M.M., et al. Phospholipid decoration of microcapsules containing perfluorooctyl bromide used as ultrasound contrast agents. Biomaterials 30 8 (2009) 1462-1472
22. Abdelwahed W., Degobert G., and Fessi H. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization. Int J Pharm 309 1-2 (2006) 178-188
23. Carstensen H., Müller B.W., and Müller R.H. Adsorption of ethoxylated surfactants on nanoparticles. I. Characterization by hydrophobic interaction chromatograhy. Int J Pharm 67 1 (1991) 29-37
24. Olivier J.-C., Vauhtier C., Taverna M., Ferrier D., and Couvreur P. Preparation and characterization of biodegradable poly(isobutylcyano acrylate) nanoparticles with the surface modified by the adsorption of proteins. Colloids Surf B Biointerfaces 4 (1995) 349-356
25. Diaz-Lopez R., Libong D., Tsapis N., Fattal E., and Chaminade P. Quantification of pegylated phospholids decorating polymeric microcapsules of perfluorooctyl bromide by reverse phase HPLC with a charged aerosol detector. J Pharm Biomed Anal 48 (2008) 702-707
26. Allemann E., Gravel P., Leroux J.C., Balant L., and Gurny R. Kinetics of blood component adsorption on poly(d, l-lactic acid) nanoparticles: evidence of complement C3 component involvement. J Biomed Mater Res 37 2 (1997) 229-234
27. Laurell C.B. Quantitative estimation of proteins by electrophoresis in agarose gels containing antibodies. Anal Biochem 15 (1966) 45-52
28. Kazatchkine M.D., Hauptmann G., and Nydegger U.E. Techniques du complément (1986), INSERM, Paris
29. Labarre D., Vauhtier C., Chauvierre C., Petri B., Müller R.H., and Chehimi M.M. Interactions of blood proteins with poly(isobutylcyanocrylate) nanoparticles decorated with a polysaccharidic brush. Biomaterials 26 (2005) 5075-5084
30. Bertholon I., Vauhtier C., and Labarre D. Complement activation by core-shell poly(isobutylcyanocryalte)polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide. Pharm Res 23 6 (2006) 1313-1323
31. Lee S.C., Oh J.T., Jang M.H., and Chung S.I. Quantitative analysis of polyvinyl alcohol on the surface of poly(d, l-lactide-co-glycolide) microparticles prepared by solvent evaporation method: effect of particle size and PVA concentration. J Control Release 59 2 (1999) 123-132
32. Boury F., Marchais H., Proust J.E., and Benoit J.P. Bovine serum albumin release from poly(a-hydroxy acid) microspheres: effects of polymer molecular weight and surface properties. J Control Release 45 (1997) 75-86
33. Shakweh M., Besnard M., Nicolas V., and Fattal E. Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice. Eur J Pharm Biopharm 61 1-2 (2005) 1-13
34. Stolnik S., Garnett M.C., Davies M.C., Illum L., Bousta M., Vert M., et al. The colloidal properties of surfactant-free biodegradable nanospheres from poly(beta-malic acid-co-benzyl malate)s and poly(lactic acid-co-glycolide). Colloids Surf A Physicochem Eng Asp 97 3 (1995) 235-245
35. Sahoo S.K., Panyam J., Prabha S., and Labhasetwar V. Residual polyvinyl alcohol associated with poly (d, l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 82 1 (2002) 105-114
36. Murakami H., Kawashima Y., Niwa T., Hino T., Takeuchi H., and Kobayashi M. Influence of the degrees of hydrolyzation and polymerization of poly(vinylalcohol) on the preparation and properties of poly(d, l-lactide-co-glycolide) nanoparticle. Int J Pharm 149 (1997) 43-49
37. Shakesheff K.M., Evora C., Soriano II, and Langer R. The adsorption of poly(vinyl alcohol) to biodegradable microparticles studied by X-ray photoelectron spectroscopy (XPS). J Colloid Interface Sci 185 2 (1997) 538-547
38. Lichtenberg D., Robson R.J., and Dennis E.A. Solubilization of phospholipids by detergents. Structural and kinetic aspects. Biochim Biophys Acta 737 2 (1983) 285-304
39. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 18 3-4 (2000) 301-313
40. Vonarbourg A., Passirani C., Saulnier P., Simard P., Leroux J.C., and Benoit J.P. Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J Biomed Mater Res A 78 3 (2006) 620-628